SCHEMBL20042796

SCHEMBL20042796

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)c1ccc(OC(F)F)cc1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
NR4A1 P22736 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GBA1 P04062 3/20 0.37
KDM4E B2RXH2 2/20 0.36
RECQL P46063 1/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MTOR P42345 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
TP53 P04637 1/20 0.35
PDE2A O00408 1/20 0.35
GCK P35557 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042794 0.89 KDM4E (0.50) P2RX7ALDH1A1HTTKDM4ERECQL
SCHEMBL20042705 0.86 EPHX2 (0.45) P2RX7LMNATP53
SCHEMBL20042917 0.85 P2RX7 (0.39) P2RX7HTTLMNAKDM4E
SCHEMBL20042685 0.85 HTT (0.42) P2RX7HTTSMN1; SMN2GBA1KCNH2
SCHEMBL20042653 0.85 P2RX7 (0.37) P2RX7LMNATSHRNR4A1SMN1; SMN2
SCHEMBL20042817 0.85 PKM (0.44) P2RX7ALDH1A1LMNAGBA1KDM4E
SCHEMBL20042911 0.85 P2RX7 (0.39) P2RX7ALDH1A1HTTLMNAKDM4E
SCHEMBL20042751 0.83 HSD17B10 (0.49) P2RX7ALDH1A1HTTLMNASMN1; SMN2
SCHEMBL20042839 0.82 P2RX7 (0.45) P2RX7ALDH1A1HTTTSHRSMN1; SMN2
SCHEMBL20042704 0.82 P2RX7 (0.50) P2RX7ALDH1A1HTTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed